🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareGLP-1 and inflammatory markers — CRP, IL-6, TNF-α reduction data Page 4

GLP-1 and inflammatory markers — CRP, IL-6, TNF-α reduction data

Dr.MetabolicMD Sat, May 9, 2026 at 4:24 AM 16 replies 510 viewsPage 4 of 4
laura_annarbor
Member
189
890
Dec 2024
Ann Arbor, MI
May 15, 2026 at 9:34 AM#16
PharmD_Rodriguez said:
Bayesian meta-analysis perspective on the trial evidence: traditional frequentist meta-analyses report point estimates and confidence intervals.

Second this. I had assumed I was the exception until I read this.

9 7labquiet_amy, emily_PDX, Dr.SleepRoch and 6 others
Reply Quote Save Share Report
Dr.GutHealth
Senior Member
1,456
7,890
Mar 2024
Minnesota
May 16, 2026 at 4:26 AM#17

The figures, for anyone assembling their own picture. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

10 8tyler_CSCS, VanRx_Mike, steve_okc and 7 others
Reply Quote Save Share Report
sarah_TO
Member
278
1,234
Sep 2024
Toronto, CA
May 16, 2026 at 11:19 PM#18

One thing that is still open after HPLC_Greg’s answer:

What would you measure differently if you were starting again?

Last edited: May 17, 2026 at 3:19 AM
11 9GraceAZ_72, carl_compliance, DanielChem_CHI and 8 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.RenalNash
VIP Member
1,234
7,890
Mar 2024
Nashville, TN
May 17, 2026 at 6:12 PM#19
Dr.GutHealth said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Not convinced. The evidence being cited is consistent with the conclusion and also consistent with two other conclusions nobody has ruled out.

12 10anders_CPH, Dr.NutriCornell, pam_stl and 9 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
May 18, 2026 at 1:05 PM#20

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here.

Last edited: May 18, 2026 at 5:05 PM
34 7PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 31 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register